Ontology highlight
ABSTRACT: Objectives
The authors investigated the topography of cholinergic vulnerability in patients with dementia with Lewy bodies (DLB) using positron emission tomography (PET) imaging with the vesicular acetylcholine transporter (VAChT) [18F]-fluoroethoxybenzovesamicol ([18F]-FEOBV) radioligand.Methods
Five elderly participants with DLB (mean age, 77.8 years [SD=4.2]) and 21 elderly healthy control subjects (mean age, 73.62 years [SD=8.37]) underwent clinical assessment and [18F]-FEOBV PET.Results
Compared with the healthy control group, reduced VAChT binding in patients with DLB demonstrated nondiffuse regionally distinct and prominent reductions in bilateral opercula and anterior cingulate to mid-cingulate cortices, bilateral insula, right (more than left) lateral geniculate nuclei, pulvinar, right proximal optic radiation, bilateral anterior and superior thalami, and posterior hippocampal fimbria and fornices.Conclusions
The topography of cholinergic vulnerability in DLB comprises key neural hubs involved in tonic alertness (cingulo-opercular), saliency (insula), visual attention (visual thalamus), and spatial navigation (fimbria/fornix) networks. The distinct denervation pattern suggests an important cholinergic role in specific clinical disease-defining features, such as cognitive fluctuations, visuoperceptual abnormalities causing visual hallucinations, visuospatial changes, and loss of balance caused by DLB.
SUBMITTER: Kanel P
PROVIDER: S-EPMC10018718 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Kanel Prabesh P Müller Martijn L T M MLTM van der Zee Sygrid S Sanchez-Catasus Carlos A CA Koeppe Robert A RA Frey Kirk A KA Bohnen Nicolaas I NI
The Journal of neuropsychiatry and clinical neurosciences 20200605 4
<h4>Objectives</h4>The authors investigated the topography of cholinergic vulnerability in patients with dementia with Lewy bodies (DLB) using positron emission tomography (PET) imaging with the vesicular acetylcholine transporter (VAChT) [<sup>18</sup>F]-fluoroethoxybenzovesamicol ([<sup>18</sup>F]-FEOBV) radioligand.<h4>Methods</h4>Five elderly participants with DLB (mean age, 77.8 years [SD=4.2]) and 21 elderly healthy control subjects (mean age, 73.62 years [SD=8.37]) underwent clinical asse ...[more]